Understanding IS Success Through IT Business Value
Journal of Organizational and End User Computing · 29.06.2026 · 38 (1) · 1-27
DOI: 10.4018/joeuc.414229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Organizational and End User Computing, erschienen am 29.06.2026. Verfasst von Thanh D. Nguyen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
This study investigates Information Systems (IS) success from an IT Business Value (ITBV) perspective by integrating constructs from the IS Success Model (ISS) and the Resource-Based View (RBV). An extended research model is developed to explain how core organizational IT resources, namely IT infrastructure and human capital, shape system perceptions, including performance expectancy, system quality, and information quality, which in turn influence IS continuance usage and ultimately firm performance. Rather than focusing on specific emerging technologies, this study emphasizes foundational IT capabilities that enable sustained system success and organizational value creation across different technological contexts. To capture multi-perspective data at the organizational level, the study employed a structured, role-based multilevel sampling strategy and tested the proposed model using covariance-based structural equation modeling (CB-SEM).
Zitieren
APA
Nguyen, T. D. (2026). Understanding IS Success Through IT Business Value. Journal of Organizational and End User Computing, 38(1), 1-27. https://doi.org/10.4018/joeuc.414229
Vancouver
Nguyen TD. Understanding IS Success Through IT Business Value. Journal of Organizational and End User Computing. 2026;38(1):1-27. doi:10.4018/joeuc.414229
BibTeX
@article{Nguyen2026,
author = {Nguyen, Thanh D.},
title = {Understanding IS Success Through IT Business Value},
journal = {Journal of Organizational and End User Computing},
year = {2026},
volume = {38},
number = {1},
pages = {1--27},
doi = {10.4018/joeuc.414229}
}
EUVIMED